Regeneron Pharmaceuticals Inc. buy Morgan Stanley
Start price
18.03.24
/
50%
€883.50
Target price
18.03.25
€1,025.4
Performance (%)
-30.96%
End price
19.03.25
€610.00
Summary
This prediction ended on 19.03.25 with a price of €610.00. The BUY prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -30.96%. Morgan_Stanley has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €0.84 are taken into consideration when calculating the performance. Morgan_Stanley has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.606% | 2.606% | -53.657% |
| iShares Core DAX® | 0.648% | -0.148% | 32.392% |
| iShares Nasdaq 100 | -0.034% | 1.859% | 14.899% |
| iShares Nikkei 225® | 2.445% | 8.129% | 8.878% |
| iShares S&P 500 | 0.492% | 1.525% | 10.604% |
Comments by Morgan_Stanley for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Morgan Stanley from $1,104.00 to $1,115.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€779.00
01.11.24
01.11.24
€1,092.0
01.11.25
01.11.25
-35.61%
16:14
16:14
Stopped prediction by Morgan_Stanley for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€479.90
10.07.25
10.07.25
€642.11
10.07.26
10.07.26
4.17%
16:14
16:14
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€428.20
02.06.25
02.06.25
€664.02
02.06.26
02.06.26
16.74%
16:14
16:14
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.00
11.07.24
11.07.24
€1,087.6
11.07.25
11.07.25
-51.07%
12.07.25
12.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€764.50
03.11.23
03.11.23
€854.04
03.11.24
03.11.24
1.87%
04.11.24
04.11.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€785.00
11.10.23
11.10.23
€861.38
11.10.24
11.10.24
17.78%
12.10.24
12.10.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€692.50
04.08.23
04.08.23
€828.28
04.08.24
04.08.24
42.96%
05.08.24
05.08.24